Both in Pharmaceuticals
Rani Therapeutics Holdings vs Rallybio
Over the past year RANI returned +63.3% and RLYB returned +286.4%; their daily moves had a correlation of -0.01.
RANI +63.3% RLYB +286.4%Growth of $1, one year, split-adjusted
| Metric | RANI | RLYB |
|---|---|---|
| Price | $0.8003 | $17.22 |
| Market cap | $92.4M | $91.5M |
| Today | +3.13% | +1.00% |
| 1 month | −4.7% | +2.4% |
| 6 months | +4.9% | +114.2% |
| Year to date | −40.7% | +213.7% |
| 1 year | +66.7% | +291.4% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −432.7% | — |
| P/E (TTM) | — | 2.0× |
| Price / sales | 18.9× | 141.6× |
| Net cash | $53.4M | $92.8M |
| Dividend yield | — | — |
| Volatility (60d) | 83.4% | 20.8% |
| Short % of float | 9.1% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).